2026 Evelyna Derhovanessian: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	44	4736	4380	308	287	99	19257

Overview

Evelyna Derhovanessian is affiliated with BioNTech in Germany and has contributed extensively to research in medicine, with a particular focus on immunology and oncology. The scientist's work spans several subfields, including oncology, immunology, infectious diseases, molecular biology, and radiology.

Their research centers on main topics such as immunotherapy and immune responses, cancer immunotherapy and biomarkers, CAR-T cell therapy research, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, RNA interference and gene delivery, and monoclonal and polyclonal antibodies research.

Recent publications authored or co-authored by Evelyna Derhovanessian include the following:

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, 2020, Nature
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer, 2023, Nature
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma, 2020, Nature
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans, 2021, Nature
BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Evelyna Derhovanessian has collaborated frequently with several co-authors, including:

Uğur Şahin
Özlem Türeci
Isabel Vogler
Daniel Maurus
Julian Sikorski

Publication venues where their research has appeared most frequently include:

Nature
Regular and Young Investigator Award Abstracts
Annals of Oncology
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research

The primary fields of study involved in the scientist's work are medicine and immunology and microbiology, with 34 and 15 publications respectively. The significant overlap between oncology and immunology in their subfield research highlights a focus on cancer-related immune mechanisms and therapeutic approaches.

Best Publications

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

Ugur Sahin;Evelyna Derhovanessian;Matthias Miller;Björn-Philipp Kloke

2535
Citations
COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses.

Ugur Sahin;Alexander Muik;Evelyna Derhovanessian;Isabel Vogler

2204
Citations
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Lena M. Kranz;Mustafa Diken;Heinrich Haas;Sebastian Kreiter

1780
Citations
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy

1374
Citations
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Unknown

1316
Citations
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

Ugur Sahin;Petra Oehm;Evelyna Derhovanessian;Robert A. Jabulowsky

946
Citations
Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

898
Citations
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Ugur Sahin;Alexander Muik;Isabel Vogler;Evelyna Derhovanessian

760
Citations
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

Benjamin Weide;Steve Pascolo;Birgit Scheel;Evelyna Derhovanessian

492
Citations
Inflammation, ageing and chronic disease

Graham Pawelec;David Goldeck;Evelyna Derhovanessian

462
Citations
Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people

Sven Koch;Sven Koch;Anis Larbi;Evelyna Derhovanessian;Dennis Özcelik

437
Citations
Cytomegalovirus and human immunosenescence.

Graham Pawelec;Evelyna Derhovanessian;Anis Larbi;Jan Strindhall

403
Citations
Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells

Benjamin Weide;Alexander Martens;Henning Zelba;Christina Stutz

283
Citations
Role of CMV in immune senescence.

Graham Pawelec;Evelyna Derhovanessian

267
Citations
Biomarkers of human immunosenescence: impact of Cytomegalovirus infection.

Evelyna Derhovanessian;Anis Larbi;Graham Pawelec

241
Citations
Senescence of the Human Immune System

G. Pawelec;A. Larbi;E. Derhovanessian

237
Citations
Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease.

Anis Larbi;Graham Pawelec;Jacek M. Witkowski;Hyman M. Schipper

224
Citations
Immunosenescence and cancer.

Graham Pawelec;Evelyna Derhovanessian;Anis Larbi

224
Citations
Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans.

Evelyna Derhovanessian;Andrea B. Maier;Karin H. Hähnel;Robert Beck

215
Citations
Immunity, ageing and cancer

Evelyna Derhovanessian;Rafael Solana;Anis Larbi;Graham Pawelec

213
Citations
CMV and Immunosenescence: from basics to clinics

Rafael Solana;Raquel Tarazona;Allison E Aiello;Arne N Akbar

207
Citations

Frequent Co-Authors

Ugur Sahin Johannes Gutenberg University of Mainz

David Capper Charité - University Medicine Berlin

Özlem Türeci BioNTech (Germany)

Hans-Georg Rammensee University of Tübingen

Stefan Stevanovic University of Tübingen

Per thor Straten University of Copenhagen

Andreas von Deimling Heidelberg University

Wolfgang Wick German Cancer Research Center

Philip R. Dormitzer Pfizer (United States)

Pei-Yong Shi GlaxoSmithKline (United Kingdom)

External Links

Personal website of Evelyna Derhovanessian

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals consider accelerated routes to quickly enter the field. For example, an nurse practitioner accelerated program allows registered nurses to advance their qualifications and expand their clinical roles efficiently.

Individuals without prior nursing experience can explore flexible options like online BSN programs for non nurses, which provide foundational nursing education through virtual platforms. These programs cater to career changers and busy professionals seeking to enter the healthcare workforce.

If speed and accessibility are priorities, many students find 12-month accelerated nursing programs appealing. These intense courses are designed to prepare students for licensing exams and clinical practice in a condensed timeframe, ideal for those eager to start their healthcare careers swiftly.

For entry-level nursing roles, exploring accredited LPN programs easy to get into can be a practical step. Licensed Practical Nurse programs provide foundational skills and allow graduates to work under registered nurses or physicians, making it a solid pathway into the healthcare system related to Immunology.